BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Biotech Beach

  Marshall Edwards, Inc. Issued New Patent For Use Of Lead Drug Candidate ME-143 In Treating Cancer

  April 25, 2012

   · 

  3 min read
• BioMidwest

  New Products from Abbott Laboratories’s EAS(R) Sports Nutrition Brand Help Athletes Improve Post-Workout Recovery and Meet Fitness Goals

  April 25, 2012

   · 

  6 min read
• Biotech Beach

  Masimo Corporation Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors

  April 25, 2012

   · 

  6 min read
• Drug Development

  AVI BioPharma, Inc. to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting

  April 25, 2012

   · 

  6 min read
• BioCapital

  NeuralStem Inc. Chief Scientific Officer To Present At Spinal Cord Injury Conference In China

  April 25, 2012

   · 

  3 min read
• BioMidwest

  Sigma-Aldrich Corporation To Present At Upcoming Investor Conferences

  April 25, 2012

   · 

  1 min read
• Business

  Zyngenia Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer

  April 25, 2012

   · 

  4 min read
• Drug Development

  Repligen Corporation Reports Positive Results From Phase 1 Clinical Trial for Spinal Muscular Atrophy (SMA)

  April 25, 2012

   · 

  1 min read
• Drug Development

  Repligen Corporation Reports Positive Results from Phase 1 Clinical Trial of RG3039 for Spinal Muscular Atrophy

  April 25, 2012

   · 

  10 min read
• BioMidwest

  Medtronic, Inc. Undergoes a Data Transplant

  April 25, 2012

   · 

  1 min read